Anthropic just exposed the playbook behind one of the most valuable products in AI. In what the company says was a simple packaging mistake, parts of the code behind Claude Code, its fast-growing AI ...

Your journey doesn’t have to end here; our Roblox Codes Section features hidden treasures for dozens of other popular experiences. Twinfinite is supported by our audience. When you purchase through ...

On the hunt for some new redeemable codes for Murder Mystery 2? You’ve come to the right place. This article will compile all of the latest codes for Murder Mystery 2 in April 2026, so you can earn ...

Honkai: Star Rail just closed out its version 4.2 livestream, teasing what’s to come in the next update, which launches the evening of April 21. Alongside new characters and events, Hoyoverse uses the ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

VentureBeat made with Google Gemini 3.1 Pro Image Anthropic appears to have accidentally revealed the inner workings of one of its most popular and lucrative AI products, the agentic AI harness Claude ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. This voice experience is generated by AI. Learn more. This ...

The more than 512,000 lines of leaked code appear to show unreleased features, instructions for Claude, and more. The more than 512,000 lines of leaked code appear to show unreleased features, ...

Security researcher Chaofan Shou discovered on March 31 that Anthropic's Claude Code CLI tool had its full TypeScript source code sitting in plain sight on the public ...

Before Neil Armstrong became the first man to walk on the Moon, he nearly died in space. During a Gemini mission, a malfunction caused the spacecraft to spin out of control at terrifying speeds. The ...

Alto Neurosciences is halting work on its schizophrenia prospect after the brain-penetrant drug flunked a phase 2 study. The Bay Area biotech evaluated 10 days of treatment with the ...